The extension to the marketing authorisation means paediatric patients aged up to 17 years with a confirmed diagnosis of ...

have lifelong allergy. Oral immunotherapy is effective for several foods including peanut, egg, and milk, and most patients achieve desensitization, allowing them to tolerate a higher threshold of ...

The European Medicines Agency’s (EMAs) Committee for Medicinal Products for Human Use (CHMP) has recommended extending the use of Stallergenes Greer’s oral immunotherapy, Palforzia (defatted ...

"This study really looked at preventing accidental ingestions, preventing anaphylaxis, and just making life a little easier ...

Four million people are unable to tolerate one of the most common food allergies in the US. The allergy typically lasts a ...

Babies with peanut allergies in Australia ... to reduce sensitivity. Oral immunotherapy has been available in clinical trials and some specialist allergy centres around the globe, but this is ...